Inhibition of Toll-like Receptor 4 With Eritoran Attenuates Myocardial Ischemia-Reperfusion Injury
- 4 July 2006
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 114 (1_suppleme), I270-4
- https://doi.org/10.1161/circulationaha.105.000901
Abstract
Background— We previously reported that the functional mutation of Toll-like receptor 4 (TLR4) in C3H/HeJ mice subjected to myocardial ischemia-reperfusion (MI/R) injury resulted in an attenuation of myocardial infarction size. To investigate the ligand-activating TLR4 during MI/R injury, we evaluated the effect of eritoran, a specific TLR4 antagonist, on MI/R injury, with the goal of defining better therapeutic options for MI/R injury. Methods and Results— C57BL/6 mice received eritoran (5 mg/kg) intravenously 10 minutes before 30 minutes of in situ of transient occlusion of the left anterior descending artery, followed by 120 minutes of reperfusion. Infarct size was measured using triphenyltetrazoliumchloride staining. A c-Jun NH 2 -terminal kinase (JNK) activation was determined by Western blotting, nuclear factor (NF)-κB activity was detected by gel-shift assay, and cytokine expression was measured by ribonuclease protection assay. Mice treated with eritoran developed significantly smaller infarcts when compared with mice treated with vehicle alone (21.0±6.4% versus 30.9±13.9%; P =0.041). Eritoran pretreatment resulted in a reduction in JNK phosphorylation (eritoran versus vehicle: 3.98±0.81 versus 7.01±2.21-fold increase; P =0.020), less nuclear NF-κB translocation (2.70±0.35 versus 7.75±0.60-fold increase; P =0.00007), and a decrease in cytokine expression ( P Conclusions— We conclude that inhibition of TLR4 with eritoran in an in situ murine model significantly reduces MI/R injury and markers of an inflammatory response.Keywords
This publication has 22 references indexed in Scilit:
- Toll-like receptor 4 mediates ischemia/reperfusion injury of the heartThe Journal of Thoracic and Cardiovascular Surgery, 2004
- Heat-shock protein 70 and heat-shock protein 90 associate with Toll-like receptor 4 in response to bacterial lipopolysaccharideBiochemical Society Transactions, 2004
- Endogenous ligands of Toll-like receptorsJournal of Leukocyte Biology, 2004
- Pharmacological therapy for myocardial reperfusion injuryCurrent Opinion in Pharmacology, 2004
- TLR signaling pathwaysSeminars in Immunology, 2004
- Modulating Toll-like receptor mediated signaling by (1→3)-β-?-glucan rapidly induces cardioprotectionCardiovascular Research, 2004
- Inhibition of Endotoxin Response by E5564, a Novel Toll-Like Receptor 4-Directed Endotoxin AntagonistThe Journal of pharmacology and experimental therapeutics, 2002
- The Endoplasmic Reticulum-resident Heat Shock Protein Gp96 Activates Dendritic Cells via the Toll-like Receptor 2/4 PathwayPublished by Elsevier BV ,2002
- Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardiumJCI Insight, 1999
- An essential role for NF-κB in the cardioadaptive response to ischemiaThe Annals of Thoracic Surgery, 1999